Khlorophylls Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 28-06-2024
- Paid Up Capital ₹ 3.00 M
as on 28-06-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 74.73%
(FY 2022)
- Profit 99.48%
(FY 2022)
- Ebitda 141.72%
(FY 2022)
- Net Worth -0.05%
(FY 2022)
- Total Assets -25.13%
(FY 2022)
About Khlorophylls Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Dakshay Thakkar, Premil Keloth, Dhrutika Thakkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PTC062011
- Company No.
062011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Khlorophylls Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Premil Keloth  | Managing Director | 17-Aug-2010 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Thakkar | Director | 31-Jan-2017 | Current |
| Dakshay Thakkar | Director | 09-Dec-2010 | Current |
| Dhrutika Thakkar | Director | 31-Jan-2017 | Current |
Financial Performance of Khlorophylls Biotech.
Khlorophylls Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 74.73% increase. The company also saw a substantial improvement in profitability, with a 99.48% increase in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Khlorophylls Biotech?
In 2020, Khlorophylls Biotech had a promoter holding of 65.00% and a public holding of 35.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Baroda Chemist Private LimitedActive 74 years 1 monthDakshay Thakkar and Dhrutika Thakkar are mutual person
- Luminary Foundation Of Entrepreneurship DevelopmentActive 7 years 5 months
Dakshay Thakkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Khlorophylls Biotech?
Unlock and access historical data on people associated with Khlorophylls Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khlorophylls Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khlorophylls Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
